Related references
Note: Only part of the references are listed.A New Combination Immunotherapy in Advanced Melanoma
Adam E. Frampton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Molecular Markers and Targets in Melanoma
Cristina Teixido et al.
CELLS (2021)
Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis
Douglas Hanniford et al.
CANCER CELL (2020)
IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives
Caterina Mancarella et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Feasibility of IMP-3 as an Invasiveness Marker for Acral Lentiginous Melanoma
Jeong-Wan Seo et al.
ANNALS OF DERMATOLOGY (2018)
Insulin-like growth factor-2 mRNA-binding protein 3 as a novel prognostic biomarker for acral lentiginous melanoma
J. W. Seo et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe
Florentia Dimitriou et al.
CURRENT ONCOLOGY REPORTS (2018)
Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival
Beatriz Sanchez-Sendra et al.
SCIENTIFIC REPORTS (2018)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer
Hans-Peter Sinn et al.
BMC CANCER (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma
Hamed Mirzaei et al.
EUROPEAN JOURNAL OF CANCER (2016)
Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma
Kaushala Jayawardana et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Translating RNA sequencing into clinical diagnostics: opportunities and challenges
Sara A. Byron et al.
NATURE REVIEWS GENETICS (2016)
MicroRNA dysregulation in melanoma
Nicholas Latchana et al.
SURGICAL ONCOLOGY-OXFORD (2016)
Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma
Yi-Shuan Sheen et al.
PLOS ONE (2016)
Cross-tissue Analysis of Gene and Protein Expression in Normal and Cancer Tissues
Idit Kosti et al.
SCIENTIFIC REPORTS (2016)
IMP-3 Promotes Migration and Invasion of Melanoma Cells by Modulating the Expression of HMGA2 and Predicts Poor Prognosis in Melanoma
Yi-Shuan Sheen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
Robert C. Doebele et al.
CANCER DISCOVERY (2015)
The Oncofetal Protein IMP3: A Novel Grading Tool and Predictor of Poor Clinical Outcome in Human Gliomas
Alessandro Del Gobbo et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Optimal Molecular Methods in Detecting p190(BCR-ABL) Fusion Variants in Hematologic Malignancies: A Case Report and Review of the Literature
Rebecca J. Sonu et al.
CASE REPORTS IN HEMATOLOGY (2015)
IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma
Yuanyuan Gao et al.
HUMAN PATHOLOGY (2014)
MicroRNAs in the pathogenesis of malignant melanoma
M. Glud et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression
Leon C. van Kempen et al.
VIRCHOWS ARCHIV (2012)
IMP3, a New Biomarker to Predict Progression of Cervical Intraepithelial Neoplasia Into Invasive Cancer
Di Lu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)
A. Noske et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
Ramon Salazar et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation
Gilberto De Castro et al.
ONCOLOGY REPORTS (2011)
IMP-3 expression in melanocytic lesions
Limin Yu et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2010)
Correlations between RNA and protein expression profiles in 23 human cell lines
Marcus Gry et al.
BMC GENOMICS (2009)
Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes
Mark J. Mentrikoski et al.
MODERN PATHOLOGY (2009)
A HUPO test sample study reveals common problems in mass spectrometry-based proteomics
Alexander W. Bell et al.
NATURE METHODS (2009)
External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma
Nathan E. Hoffmann et al.
CANCER (2008)
Combination of quantitative IMP3 and tumor stage: A new system to predict metastasis for patients with localized renal cell carcinomas
Zhong Jiang et al.
CLINICAL CANCER RESEARCH (2008)
IMP-3 is a novel progression marker in malignant melanoma
Jennifer G. Pryor et al.
MODERN PATHOLOGY (2008)
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer
Richard Booton et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Global survey of organ and organelle protein expression in mouse: Combined proteomic and transcriptomic profiling
T Kislinger et al.
CELL (2006)
RNA-binding IMPs promote cell adhesion and invadopodia formation
J Vikesaa et al.
EMBO JOURNAL (2006)
Class III β-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel
P Sève et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Discordant protein and mRNA expression in lung adenocarcinomas
GA Chen et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and β-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations
D Goidin et al.
ANALYTICAL BIOCHEMISTRY (2001)
Share Paper
